Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Economics and Human Biology|December 10, 2015
A comparison of diagnosed and undiagnosed diabetes patients and labor supplyTravis Minor, Joanna P MacEwanThe American Journal of Managed Care|January 31, 2018
Quality measure improvement strategies for elderly patients with diabetesJohn J Sheehan, Joanna P MacEwanJournal of Managed Care & Specialty Pharmacy|January 27, 2017
The Value of Survival Gains in Pancreatic Cancer from Novel Treatment RegimensJoanna P MacEwan, Wes Yin, Satyin Kaura, et al.Therapeutic Advances in Hematology|July 19, 2021
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myelomaJoanna P MacEwan, Istvan Majer, Jacquelyn W Chou, et al.The American Journal of Managed Care|February 1, 2017
The value of survival gains in myelodysplastic syndromesJoanna P MacEwan, Wes Yin, Satyin Kaura, et al.Forum for Health Economics & Policy|August 18, 2019
Returns to Society from Investment in Cancer Research and DevelopmentAmitabh Chandra, Joanna P MacEwan, Avrita Campinha-Bacote, et al.MDM Policy & Practice|June 18, 2020
Non-Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice ExperimentJoanna P MacEwan, Komal Gupte-Singh, Lauren M Zhao, et al.Journal of Medical Economics|November 9, 2020
Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016Joanna P MacEwan, Syvart Dennen, Rebecca Kee, et al.The American Journal of Managed Care|November 1, 2017
What do pharmaceuticals really cost in the long run?Darius Lakdawalla, Joanna P MacEwan, Robert Dubois, et al.JCO Oncology Practice|February 17, 2023
Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With CancerKelly Birch, Sukyung Chung, Sean R Zion, et al.Pageof 4